Ionis Pharmaceuticals, Inc. IONS 深 滬
等待開盤 08-21 09:30:00 美东时间
58.76
-2.040
-3.36%
華盛通- 最 高60.41
- 今 開60.025
- 成交量 212.48万股
- 最 低 58.60
- 昨 收 60.80
- 總市值 97.65亿
- 52周最高 86.74
- 市盈率 靜 --
- 換手率 1.28%
- 52周最低 49.13
- 委 比 -96.69%
- 總股本 1.66亿
- 歷史最高 86.74
- 量 比 0.97
- 振 幅 2.98%
- 歷史最低 6.25
- 每 手 1
- 風險率 10.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅1610.53%！Ascendiant Capital上调Alzamend Neuro目标价至26美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Alzamend Neuro"买入"评级，目标价从25美元升至26美元；Tigress Financial：维持Legence"买入"评级，目标价从125美元升至130美元
08-20 08:39
BMO Capital Initiates Coverage On Ionis Pharmaceuticals with Market Perform Rating, Announces Price Target of $60
BMO Capital analyst David Lebowitz initiates coverage on Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform rating and announces Price Target of $60.
08-19 18:45
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often look for circumstances when the market estimation of an option diverges away fro...
08-19 01:35
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Praxis Precision Medicines reported progress on its CNS pipeline, including successful mid-cycle meetings for ulixacaltamide HCl and relutrigine with no major safety concerns from the FDA, and PDUFA dates set for January 2027 and December 2026, respectively. The company also completed FDA BIMO inspections without Form 483 observations. Commercial preparations are advancing for both programs. Additionally, Praxis received a Breakthrough Therapy De...
08-06 12:00
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
McCormick, Wabtec, Ecolab, Ionis, Fastenal Insider Shock
Insiders have been trading these 5 stocks: (($MKC)), (($WAB)), (($ECL)), (($ION...
08-01 21:01
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) stock plunged on Thursday after the company lowered its fiscal 2026 guidance. The company reported second-quarter adjusted earnings of $1.84 per share, beating the consensus of $1.55. Sales jumped 67% year over year to $1.291 billion, missing the consensus ...
07-31 02:37
Cytokinetics wins U.K. nod, NICE endorsement for heart drug
Cytokinetics (CYTK) announced on Thursday that the U.K. drug regulator approved its heart disease medication, Myqorzo (aficamten), and concurrently, the country’s health spending watchdog, the Nationa...
07-30 20:50
Microsoft To Rally More Than 40%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays cut the price target for Meta Platforms Inc (NASDAQ:META) from $830 to $780. Barclays analyst Ross Sa...
07-30 20:15
